Delta-Selective Ligands Related to Naltrindole

2003 ◽  
pp. 157-176
Keyword(s):  
ChemInform ◽  
2009 ◽  
Vol 40 (29) ◽  
Author(s):  
Chris Dockendorff ◽  
Shujuan Jin ◽  
Madeline Olsen ◽  
Mark Lautens ◽  
Martin Coupal ◽  
...  

2020 ◽  
Vol 63 (6) ◽  
pp. 3090-3103 ◽  
Author(s):  
Jussara Amato ◽  
Giulia Miglietta ◽  
Rita Morigi ◽  
Nunzia Iaccarino ◽  
Alessandra Locatelli ◽  
...  

2018 ◽  
Vol 93 (3) ◽  
pp. 197-207 ◽  
Author(s):  
Carlos G. Coriano ◽  
Fabao Liu ◽  
Chelsie K. Sievers ◽  
Muxuan Liang ◽  
Yidan Wang ◽  
...  

Author(s):  
Keita Iio ◽  
Noriki Kutsumura ◽  
Yasuyuki Nagumo ◽  
Tsuyoshi Saitoh ◽  
Akihisa Tokuda ◽  
...  
Keyword(s):  

2015 ◽  
Vol 25 (19) ◽  
pp. 4174-4178 ◽  
Author(s):  
Kiminori Ohta ◽  
Takumi Ogawa ◽  
Akifumi Oda ◽  
Asako Kaise ◽  
Yasuyuki Endo

1991 ◽  
Vol 159 (S12) ◽  
pp. 7-14 ◽  
Author(s):  
P. J. Cowen

Serotonin (5-HT) interacts with multiple brain 5-HT receptor subtypes to influence a wide range of behaviours. Three main families of 5-HT receptors (5-HT1, 5-HT2 and 5-HT3) have been described which differ in their binding affinity for selective ligands, their receptor-effector coupling mechanisms, and the behavioural processes they regulate. Nevertheless, manipulation of several different 5-HT receptor subtypes (5-HT1A, 5-HT1c, 5-HT2 and 5-HT3) may produce anxiolytic effects; 5-HT1A and 5-HT2 receptors may be involved in the aetiology of major depression and the therapeutic effects of antidepressant treatment; and 5-HT3 receptors have been linked to reward mechanisms and cognitive processes. These advances offer therapeutic possibilities, the value of which can only be satisfactorily assessed by controlled clinical trials.


1996 ◽  
Vol 39 (12) ◽  
pp. 2411-2421 ◽  
Author(s):  
Kuo-Long Yu ◽  
Patrick Spinazze ◽  
Jacek Ostrowski ◽  
Stephen J. Currier ◽  
Edward J. Pack ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document